Skip to main content
CAG
NYSE Manufacturing

Conagra Q1 FY27: EPS Beats, But Operating Cash Flow Turns Negative on Litigation Payouts

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Food & Beverage Stocks · Consumer
Sentiment info
Negative
Importance info
7
Price
$13.44
Mkt Cap
$6.432B
52W Low
$12.53
52W High
$20.316
52W Position info
7.3% above low
Off High info
34% below high
Rel. Volume info
2.9× avg
Market data snapshot near publication time

CAG is trading near its 52-week low of $12.53 (7.3% above the low) on elevated volume (2.9× avg).

Summary

Conagra beat Q1 FY27 adjusted EPS estimates, but operating cash flow turned negative on litigation payouts, and the company flagged heightened impairment risk in its Refrigerated & Frozen unit.


Key Events · Earnings and Guidance · CAG

  • Q1 FY27 EPS Beats, Sales Dip

    Adjusted EPS of $0.41 beat the $0.28 consensus by 46%; GAAP diluted EPS was $0.36 vs $0.34 a year ago. Net sales fell 1.4% to $2,595.9M.

  • Operating Cash Flow Turns Negative

    Operating cash flow was -$4.2M vs +$120.6M in Q1 FY26, driven by higher cooking-spray litigation payments and lower operating profit.

  • Litigation Payments Mount

    Conagra paid an additional $44.3M in Q1 FY27 for Pam cooking spray settlements, and a $22.9M final judgment in the diacetyl case is under appeal.

  • Refrigerated & Frozen Impairment Risk

    The Refrigerated & Frozen reporting unit has zero excess fair value over carrying amount after fiscal 2026 write-downs, creating heightened risk of future impairments.


Analysis · CAG · Manufacturing

Conagra's Q1 FY27 adjusted EPS of $0.41 beat consensus by 46%, but the 10-Q reveals operating cash flow swung to a $4.2M use of cash from a $120.6M source a year ago, driven by higher cooking-spray litigation payments. The company also issued $500M of new 5.40% notes, repurchased $44M of stock, and disclosed that its Refrigerated & Frozen reporting unit now has zero excess fair value over carrying amount — a heightened impairment risk. Against the backdrop of the $1.92B fiscal 2026 net loss and halved dividend, the cash-flow deterioration and litigation overhang matter more than the headline EPS beat.

How filings like this one have moved

In the 30 days to Nov 9, 2026, 36.6% of the 2965 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, CAG was trading at $13.44 on NYSE in the Manufacturing sector, with a market capitalization of approximately $6.4B. The 52-week trading range was $12.53 to $20.32. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CAG - Latest Insights

CAG
Sep 30, 2026, 12:52 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $13.79
Real-time Price: $15.17 info
Change: +$1.37 (+10%) info
Market Cap: $7.24B info
CAG
Sep 30, 2026, 7:43 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $14.48
Real-time Price: $15.17 info
Change: +$0.685 (+5%) info
Market Cap: $7.24B info
CAG
Aug 11, 2026, 8:32 AM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $14.75
Real-time Price: $15.17 info
Change: +$0.415 (+3%) info
Market Cap: $7.24B info
CAG
Jul 21, 2026, 6:01 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $14.82
Real-time Price: $15.17 info
Change: +$0.345 (+2%) info
Market Cap: $7.24B info
CAG
Jul 15, 2026, 4:31 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $14.13
Real-time Price: $15.17 info
Change: +$1.04 (+7%) info
Market Cap: $7.24B info